Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease

Liver Transplantation

Volumn 7, Issue 7, 2001, Pages 608-614

  Charlton, Michael ^a   Kasparova, Pavla ^a   Weston, Shiobhan ^a   Lindor, Keith ^a   Maor Kendler, Yaakov ^a   Wiesner, Russell H ^a   Rosen, Charles B ^a   Batts, Kenneth P ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ANAMNESIS; ARTICLE; CHOLESTASIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EVALUATION; FEMALE; HEPATITIS; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT; RECURRENT DISEASE; STEATOSIS; TIME;

EID: 0034925012     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2001.25453     Document Type: Article

References (46)

1. The liver in obesity
2. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
3. Nonalcoholic steatohepatitis
4. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients
5. Nonalcoholic steatohepatitis: Tightening the morphological screws on a hepatic rambler
6. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years
7. The natural history of nonalcoholic fatty liver: A follow-up study
8. The clinical associations with hepatic steatosis: A retrospective study
9. Liver pathology in morbidly obese patients with and without diabetes
10. Hepatic morphology in obesity
11. Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus
12. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis
13. The high prevalence of obesity in Michigan primary care practices. An UPRNet study
14. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults
15. Adolescent obesity increases significantly in second and third generation US immigrants: The National Longitudinal Study of Adolescent Health
16. Overweight and obesity in the United States: Prevalence and trends, 1960-1994
17. Recurrence of nonalcoholic steatohepatitis following liver transplantation
18. Chronic hepatitis: An update on terminology and reporting
19. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
20. Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation
21. Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient
22. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors
23. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
24. Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis
25. Resting energy expenditure in patients with end-stage liver disease and in normal population
26. Energy metabolism in patients with acute and chronic liver disease
27. Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases
28. Liver transplantation for cryptogenic cirrhosis
29. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease
30. Relation of protease inhibitor phenotypes to obstructive lung diseases in a community
31. 1-antitrypsin phenotypes in chronic active liver disease and primary biliary cirrhosis
32. 1-antitrypsin variants. Prevalence and clinical spirometry
33. Antitrypsin phenotypes in Saint-Louis
34. 1-antitrypsin deficiency
35. l-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis
36. 1-antitrypsin deficiency identified by a Pi Z-specific monoclonal antibody
37. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis
38. Host- and disease-specific factors affecting steatosis in chronic hepatitis C
39. Plasma amino acid levels and insulin secretion in obesity
40. Mineral homeostasis in obesity: Effects of euglycemic hyperin-sulinemia
41. Differential effects of insulin resistance on leucine and glucose kinetics in obesity
42. Does long-term home parenteral nutrition in adult patients cause chronic liver disease?
43. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes
44. Alterations in liver ATP homeostasis in human non-alcoholic steatohepatitis: A pilot study
45. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis
46. Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis